From a portfolio view, I’m keeping SMCI a tiny satellite versus NVDA and MU. If growth decelerates further, I’ll rotate more into cash and wait for clearer demand signals before adding.
Kinda torn here—feels like a sell-the-news moment, but I’m nibbling small if it dips on the guidance cut.
I’ve seen this movie with AI memory stocks before: flashy growth, then rate hikes hit and margins compress. Guidance cuts often precede a reset. Without clear catalysts, I’m not convinced this is a trend reversal yet.
Everyone's bullish; I'm fading this pop.
Newbie question: what does 'into it' mean for $CELH? Is this just hype or real progress toward trials and funding?
Everyone cheering $CELH like it's a breakout, but I'm not buying the hype. The price action looks more like a squeeze than conviction. Without real catalysts—clinical data, partnerships, or revenue—how sustainable is this momentum?
Not convinced; this feels like FOMO marketing.
Holding GBTC and BTC; still uneasy about this drama.
I’m not chasing GBTC after this. If it’s a final sale, I’d rather wait for clearer trends in BTC or a spot ETF.
